# TArget Trial Emulation Comparing Effectiveness of Tocilizumab vs Methotrexate In Corticosteroid-Treated GCA Patients

> **NCT07459335** · — · COMPLETED · sponsor: **Groupe français d'étude des Maladies Inflammatoires de loeil** · enrollment: 1667 (actual)

## Conditions studied

- Giant Cell Arteritis (GCA)
- Cardiovascular Diseases

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07459335
- **Lead sponsor:** Groupe français d'étude des Maladies Inflammatoires de loeil
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 1667 (ACTUAL)
- **Last updated:** 2026-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07459335

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07459335, "TArget Trial Emulation Comparing Effectiveness of Tocilizumab vs Methotrexate In Corticosteroid-Treated GCA Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07459335. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*